Article
Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.
Molecular and cellular neurosciences - 1 Dec 2005
Cong Shu-Yan, Pepers Barry A, Evert Bernd O, Rubinsztein David C, Roos Raymund A C, van Ommen Gert-Jan B, Dorsman Josephine C
Abstract excerpt
Huntington's disease can be used as a model to study neurodegenerative disorders caused by aggregation-prone proteins. It has been proposed that the entrapment of transcription factors in aggregates plays an important role in pathogenesis. We now report that the transcriptional activity of CBP is already repressed in the early time points by soluble mutant huntingtin, whereas the histone acetylase activity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
